Cat.No.L2900
A unique collection of 155 small molecules for exploring the development of diabetes.
Cited by 324 Publications
• A unique collection of 155 small molecules for exploring the development of diabetes.
• Targets including both type 1 and type 2 diabetes modulators: DPP-4, GPR, Potassium Channel, PPAR, SGLT, etc.
• Structurally diverse, medicinally active, and cell permeable.
• Rich documentation with structure and customer reviews.
• NMR and HPLC validated to ensure high purity.
| Formulation | 146 compounds pre-dissolved in 10mM DMSO, 5 compounds pre-dissolved in 10mM water and 4 compounds pre-dissolved in 2mM DMSO | ||
|---|---|---|---|
| Container | 96 Deep Well Plate Sealed With Aluminium Foil | ||
| Stability | 12 months | -20°C | in DMSO |
| 24 months | -80°C | in DMSO | |
| Shipping | Blue ice or dry ice | ||
Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF
Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF
Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF
Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF
Application of Epigenetics Compound Library in acute lymphoblastic leukaemia (This article was published in Blood (IF
Application of Inhibitor Library in tumour immunology (This article was published in Cancer Immunol Res (IF